Ilyang Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
Alternative corporations in the scoring industry group for Ilyang Pharmaceutical Co Ltd are shown below. If you work at Ilyang Pharmaceutical Co Ltd and you would like to use your ESG rating, please contact us. The page contains a free ESG assessment for Ilyang Pharmaceutical Co Ltd.
Ilyang Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.5; made up of an environmental score of 0.0, social score of 0.0 and governance score of 1.6.
0.5
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1898 | Zota Health Care Ltd | 0.7 | Low |
1898 | cbdMD Inc | 0.7 | Low |
1924 | Ilyang Pharmaceutical Co Ltd | 0.5 | Low |
1924 | Beximco Pharmaceuticals Ltd | 0.5 | Low |
1924 | Acucela Inc | 0.5 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Ilyang Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Ilyang Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Ilyang Pharmaceutical Co Ltd report the average age of the workforce?
Does Ilyang Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Ilyang Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Ilyang Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Ilyang Pharmaceutical Co Ltd offer flexible work?
Does Ilyang Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Ilyang Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Ilyang Pharmaceutical Co Ltd conduct supply chain audits?
Does Ilyang Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Ilyang Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Ilyang Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Ilyang Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Ilyang Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Ilyang Pharmaceutical Co Ltd disclose water use targets?
Does Ilyang Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Ilyang Pharmaceutical Co Ltd have a product recall in the last two years?
Does Ilyang Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Ilyang Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Ilyang Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Ilyang Pharmaceutical Co Ltd disclose parental leave metrics?
Does Ilyang Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Ilyang Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Ilyang Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Ilyang Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Ilyang Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Ilyang Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Ilyang Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Ilyang Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Ilyang Pharmaceutical Co Ltd disclose its waste policy?
Does Ilyang Pharmaceutical Co Ltd report according to TCFD requirements?
Does Ilyang Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Ilyang Pharmaceutical Co Ltd disclose energy use targets?
Does Ilyang Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Ilyang Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Ilyang Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products. Ilyang Pharmaceutical Co.,Ltd also exports its products to approximately 14 countries. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991. Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin, South Korea.